NCT00904449View on ClinicalTrials.gov

Open Label Assessment of Long-Term Safety and Utility

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Pain
Interventions
DRUG

Oxymorphone ER

10mg, 20mg, and 40mg PO

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY